Copyright
©The Author(s) 2021.
World J Diabetes. Jul 15, 2021; 12(7): 1093-1101
Published online Jul 15, 2021. doi: 10.4239/wjd.v12.i7.1093
Published online Jul 15, 2021. doi: 10.4239/wjd.v12.i7.1093
Diarem | Diarem2 | IMS | ABCD | Duke diabetes remission | |
Procedure | Rygb | RYGB | RYGB or SG | RYGB or mini-gastric | RYGB, SG, AGB, BPD/DS |
Number of patients (n) | 690 | 307 | 659 | 63 | 602 |
Variables | Insulin use | Insulin use | Insulin use | Diabetes duration | Age |
Sex | |||||
Age | Age | Duration of diabetes | Age | Race | |
Insulin use | |||||
Hba1c | Hba1c | Hba1c | Baseline BMI | Hba1c | |
BMI | |||||
Type of antidiabetic drugs | Duration of diabetes | Number of diabetic medications | C-peptide level | Preop asthma, GERD, hypertension, hyperlipidemia, anticoagulation medication status | |
Type of antidiabetic drugs | |||||
Scale | 0-22 (5 groups) | 0-25 (High-Intermediate-Low remission) | 3 stages (Mild-Moderate-Severe) | 0-10 | Odds of remission according to preoperative variables and type of surgery |
Recommendation on procedure of choice | No | No | Yes | No | No |
- Citation: Chumakova-Orin M, Vanetta C, Moris DP, Guerron AD. Diabetes remission after bariatric surgery. World J Diabetes 2021; 12(7): 1093-1101
- URL: https://www.wjgnet.com/1948-9358/full/v12/i7/1093.htm
- DOI: https://dx.doi.org/10.4239/wjd.v12.i7.1093